MEDFX
Price
$12.51
Change
-$0.08 (-0.64%)
Updated
Sep 11 closing price
Net Assets
7.51B
REBAX
Price
$9.92
Change
-$0.01 (-0.10%)
Updated
Sep 11 closing price
Net Assets
356.62M
Interact to see
Advertisement

MEDFX vs REBAX

MEDFX vs REBAX Comparison Chart in %
View a ticker or compare two or three
VS
MEDFX vs. REBAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDFX is a Hold and REBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDFX has more cash in the bank: 7.51B vs. REBAX (357M). MEDFX pays higher dividends than REBAX: MEDFX (5.33) vs REBAX (4.81). MEDFX was incepted earlier than REBAX: MEDFX (18 years) vs REBAX (21 years). REBAX (1.11) and MEDFX (1.08) have similar cost to investors . MEDFX is a more actively managed with annual turnover of: 69.00 vs. REBAX (42.00). MEDFX has a lower initial minimum investment than REBAX: MEDFX (0) vs REBAX (2000). MEDFX annual gain was more profitable for investors over the last year : 5.29 vs. REBAX (3.95). MEDFX return over 5 years is better than : 11.15 vs. REBAX (8.23).
MEDFXREBAXMEDFX / REBAX
Total Expense Ratio1.071.1196%
Annual Report Gross Expense Ratio1.081.1197%
Fund Existence18 years21 years-
Gain YTD1.7641.112159%
Front LoadN/A5%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.51B357M2,105%
Annual Yield % from dividends5.334.81111%
Returns for 1 year5.293.95134%
Returns for 3 years31.1029.77104%
Returns for 5 years11.158.23135%
Returns for 10 years37.7130.87122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVAX24.510.20
+0.82%
American Beacon Large Cap Value A
POVYX34.80N/A
N/A
Putnam International Equity Y
HDGCX36.65N/A
N/A
Hartford Dividend and Growth C
RSGFX10.91N/A
N/A
Victory RS Select Growth C
MNBRX19.77N/A
N/A
Manning & Napier Pro-Blend Extnd Term R